Common Formats for Patient Safety Data Collection and Event Reporting, 22322-22324 [2012-8743]
Download as PDF
22322
Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices
FOR FURTHER INFORMATION CONTACT:
Nominations of assays should be
submitted online at https://
iccvam.niehs.nih.gov/contact/Tox21nomination.htm (preferred means) or to
Dr. Warren Casey, Deputy Director,
NICEATM, NIEHS, P.O. Box 12233,
Mail Stop: K2–16, Research Triangle
Park, NC 27709, (telephone) 919–541–
2384, (fax) 919–541–0947, (email)
niceatm@niehs.nih.gov. Courier address:
NICEATM, NIEHS, Room 2034, 530
Davis Drive, Morrisville, NC 27560.
SUPPLEMENTARY INFORMATION:
pmangrum on DSK3VPTVN1PROD with NOTICES
Background
The Tox21 Consortium is a
collaboration of the NIH Center for
Translational Therapeutics (NCTT),1
NIEHS/NTP,2 U.S. Environmental
Protection Agency (EPA),3 and U.S.
Food and Drug Administration (FDA).4
The goal of Tox21 is to develop,
validate, and translate innovative HTS
methods to characterize the impact of
chemicals on key steps in toxicity
pathways and ultimately to provide
tools to risk assessors to protect human
health and the environment.
The Tox21 HTS Initiative aims to
prioritize substances for in-depth
toxicological evaluation, identify
mechanisms of action for further
investigation, and develop predictive
models for in vivo biological responses
using efficient, high throughput in vitro
assays. Tox21 also aims to expand the
ability to screen environmental
compounds for organ-specific toxicity,
focusing in particular on the liver,
kidney, and nervous system.
The current Tox21 inventory of
10,000 chemicals covers a variety of
classifications, including consumer
products, food additives, human and
veterinary drugs, manufacturing
intermediates, and pesticides. These
10,000 chemicals are being profiled
using HTS assays designed to estimate
toxicity potential and identify the
specific perturbations they induce in
biological pathways.
Request for Nominations of HTS Assays
NICEATM requests nominations of in
vitro HTS toxicity assays that might be
used in the Tox21 testing program.
Tox21 intends to develop a systematic
view of how chemicals interact with
and affect biological systems using its
collection of 10,000 chemicals. To
achieve this goal, assays, which target
all pathways relevant to toxicity, are
needed to assess chemicals’ effects.
1 https://nctt.nih.gov/27543703.
2 https://ntp.niehs.nih.gov/go/28213.
3 https://www.epa.gov/ncct/Tox21/.
4 https://www.fda.gov/.
VerDate Mar<15>2010
14:16 Apr 12, 2012
Jkt 226001
Nominated assays will be assessed for
their overall applicability to the Tox21
HTS program in terms of biological
relevance, cost, and potential for
adaption to a HTS format. Suitable
assays will then be prioritized for use by
the NCTT. Protocol information and test
data submitted in response to this notice
may be incorporated into future NCTT
and NICEATM reports and publications
as appropriate.
Nominations should consider the
following general criteria: (1) Relevance
to the goals of the Tox21 Initiative
(https://nctt.nih.gov/27543703), (2) high
throughput capability of the assay (96well format or higher, with no obvious
impediments to miniaturization to a
1536-well format), (3) evaluation of
preliminary assay performance using
appropriate reference compounds, (4)
validation status of the assay, (5)
availability of complete detailed
protocols, and (6) efficiency and cost of
the assay. A list of compatibility criteria
for 1536-well biochemical and cellbased assays is available at https://
nctt.nih.gov/27545107.
Assay nominations should be
submitted electronically using the
online form (https://
iccvam.niehs.nih.gov/contact/Tox21nomination.htm). When submitting HTS
assay nominations and protocol
information, please reference this
Federal Register notice and provide
appropriate contact information (name,
affiliation, mailing address, phone, fax,
email, and sponsoring organization as
applicable). NICEATM prefers
submission of the nominations via the
Web site identified above; however,
submissions by mail, fax, or email are
acceptable. Questions about the
submission process should be directed
to Dr. Warren Casey (see FOR FURTHER
INFORMATION CONTACT).
that more accurately assess the safety
and hazards of chemicals and products
and that will reduce, refine (enhance
animal well-being and decrease or
eliminate pain and distress), or replace
animal use. NICEATM also conducts
independent validation studies to assess
the usefulness and limitations of new,
revised, and alternative test methods
and strategies applicable to the safetytesting needs of Federal agencies. In
2012, NICEATM began providing
support to Tox21 regarding HTS assay
nomination and review.
NICEATM and ICCVAM welcome the
public nomination of new, revised, and
alternative test methods and strategies
applicable to the needs of Federal
agencies. Additional information about
NICEATM can be found on the
NICEATM–ICCVAM Web site (https://
iccvam.niehs.nih.gov).
Dated: April 5, 2012.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. 2012–8942 Filed 4–12–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Common Formats for Patient Safety
Data Collection and Event Reporting
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Notice of Availability—New
Common Format.
AGENCY:
As authorized by the
Secretary of HHS, AHRQ coordinates
the development of a set of common
definitions and reporting formats
Background Information on NICEATM
(Common Formats) for reporting patient
NICEATM was established in 1998 to
safety events to Patient Safety
administer and provide scientific
Organizations (PS0s). The purpose of
support for the Interagency
this notice is to announce the
Coordinating Committee on the
availability of new Common Formats—
Validation of Alternative Methods
Hospital Version 1.2 for public review
(ICCVAM), which is composed of 15
and comment.
member Federal agencies and includes
DATES: Ongoing public input.
the EPA, FDA, NIEHS, and NIH. The
ADDRESSES: The new Common
ICCVAM Authorization Act of 2000 (42
U.S.C. 285l–2, 285l-5, available at https:// Formats—Hospital Version 1.2, version
dated April 2012, and the remaining
iccvam.niehs.nih.gov/about/
Common Formats can be accessed
PL106545.htm) established ICCVAM as
electronically at the following HHS Web
a permanent interagency committee of
the NIEHS under NICEATM. NICEATM site: https://www.PSO.AHRQ.gov/
index.html.
and ICCVAM conduct technical
evaluations of new, revised, and
alternative safety testing methods with
regulatory applicability and promote the
scientific validation and regulatory
acceptance of safety-testing methods
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Cathryn Niane, Center for Quality
Improvement and Patient Safety, AHRQ,
540 Gaither Road, Rockville, MD 20850;
Telephone (toll free): (866) 403–3697;
E:\FR\FM\13APN1.SGM
13APN1
Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices
Telephone (local): (301) 427–1111; TTY
(toll free): (866) 438–7231; TTY (local):
(301) 427–1130; Email:
PSO.AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety and Quality
Improvement Act of 2005, 42 U.S.C.
299b–21 to b–26, (Patient Safety Act)
provides for the formation of PS0s,
which collect, aggregate, and analyze
confidential information regarding the
quality and safety of healthcare
delivery. The Patient Safety Act (at 42
U.S.C. 299b–23) authorizes healthcare
providers to voluntarily collect and
submit in a standardized manner, as
explained in the related Patient Safety
and Quality Improvement Final Rule, 42
CFR part 3 (Patient Safety Rule),
published in the Federal Register on
November 21, 2008: 73 FR 70731–
70814. The collection of patient safety
work product allows the aggregation of
sufficient data to identify and address
underlying causal factors of patient
safety problems.
The Patient Safety Act and Patient
Safety Rule establish a framework by
which doctors, hospitals, skilled
nursing facilities, and other healthcare
providers may assemble information
regarding patient safety events and
quality of care. Information that is
assembled and developed by providers
for reporting to PSOs and the
information received and analyzed by
PSOs—called ‘‘patient safety work
product’’—is privileged and
confidential. Patient safety work
product is used to identify events,
patterns of care, and unsafe conditions
that increase risks and hazards to
patients. Definitions and other details
about PSOs and patient safety work
product are included in the Patient
Safety Act and Patient Safety Rule
which can be accessed electronically at:
https://www.PSO.AHRQ.gov/
REGULATIONS/REGULATIONS.htm.
pmangrum on DSK3VPTVN1PROD with NOTICES
Definition of Common Formats
The term ‘‘Common Formats’’ refers
to the common definitions and reporting
formats, specified by AHRQ, that allow
health care providers to collect and
submit standardized information
regarding patient safety events. The
Common Formats are not intended to
replace any current mandatory reporting
system, collaborative/voluntary
reporting system, research-related
reporting system, or other reporting/
recording system; rather the formats are
intended to enhance the ability of health
care providers to report information that
VerDate Mar<15>2010
14:16 Apr 12, 2012
Jkt 226001
is standardized both clinically and
electronically.
In collaboration with the interagency
Federal Patient Safety Workgroup
(PSWG), the National Quality Forum
(NQF) and the public, AHRQ has
developed Common Formats for two
settings of care—acute care hospitals
and skilled nursing facilities—in order
to facilitate standardized data
collection. The scope of Common
Formats applies to all patient safety
concerns including: Incidents—patient
safety events that reached the patient,
whether or not there was harm; near
misses or close calls—patient safety
events that did not reach the patient;
and unsafe conditions—circumstances
that increase the probability of a patient
safety event.
AHRQ’s Common Formats include:
• Event descriptions (descriptions of
patient safety events and unsafe
conditions to be reported);
• Specifications for patient safety
aggregate reports and individual event
summaries;
• Delineation of data elements to be
collected for different types of events to
populate the reports;
• A user’s guide and quick guide, and
• Technical specifications for
electronic data collection and reporting.
The technical specifications promote
standardization of collected patient
safety event information by specifying
rules for data collection and submission,
as well ’as by providing guidance for
how and when to create data elements,
their valid values, conditional and go-to
logic, and reports. These specifications
will ensure that data collected by PSOs
and other entities have comparable
clinical meaning. They also provide
direction to software developers, so that
the Common Formats can be
implemented electronically, and to
PS0s, so that the Common Formats can
be submitted electronically to the PSO
Privacy Protection Center (PPC) for data
de-identification and transmission to
the Network of Patient Safety Databases
(NPSD).
The Common Formats include two
general types of formats, generic and
event-specific. The generic Common
Formats pertain to all patient safety
concerns. The three generic formats are:
Healthcare Event Reporting Form,
Patient Information Form, and Summary
of Initial Report. The event-specific
Common Formats pertain to frequentlyoccurring and/or serious patient safety
events.
Since the initial release of the
Common Formats in August 2008,
AHRQ regularly revises the formats
based upon public comment. The
Common Formats—Hospital Version 1.2
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
22323
features new content to incorporate the
event specific formats entitled Venous
Thromboembolism (VTE) and Device or
Medical/Surgical Supply including
Health Information Technology (HIT)
Device. Common Formats—Hospital
Version 1.2, which also includes minor
changes to existing modules and
technical specifications, is available at
the PSO PPC Web site: https://
www.PSOPPC.ORG/web/patientsafety.
Common Formats Development
In anticipation of the need for
Common Formats, AHRQ began their
development by creating an inventory of
functioning private and public sector
patient safety reporting systems. This
inventory provides an evidence base
that informs construction of the
Common Formats. The inventory
includes many systems from the private
sector, including prominent academic
settings, hospital systems, and
international reporting systems (e.g.,
from the United Kingdom and the
Commonwealth of Australia). In
addition, virtually all major Federal
patient safety reporting systems are
included, such as those from the Centers
for Disease Control and Prevention
(CDC), the Food and Drug
Administration (FDA), the Department
of Defense (DoD), and the Department of
Veterans Affairs (VA).
Since February 2005, AHRQ has
convened the PSWG to assist AHRQ
with developing and maintaining the
Common Formats. The PSWG includes
major health agencies within HHS—
CDC, Centers for Medicare & Medicaid
Services, FDA, Health Resources and
Services Administration, Indian Health
Service, National Institutes of Health,
National Library of Medicine, Office of
the National Coordinator for Health
Information Technology, Office of
Public Health and Science, and
Substance Abuse and Mental Health
Services Administration—as well as the
DoD and VA.
When developing Common Formats,
AHRQ first reviews existing patient
safety event reporting systems from a
variety of health care organizations. In
collaboration with the PSWG and
Federal subject matter experts, AHRQ
drafts and releases beta versions of the
Common Formats for public review and
comment. The PSWG assists AHRQ
with assuring the consistency of
definitions/formats with those of
relevant government agencies as
refinement of the Common Formats
continues. To the extent practicable, the
Common Formats are also aligned with
World Health Organization (WHO)
concepts, framework, and definitions
E:\FR\FM\13APN1.SGM
13APN1
22324
Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices
contained in their draft International
Classification for Patient Safety (ICPS).
Commenting on Common Formats
Hospital 1.2
To allow for greater participation by
the private sector in the subsequent
development of the Common Formats,
AHRQ engaged the NQF, a non-profit
organization focused on health care
quality, to solicit comments and advice
to guide the further refinement of the
Common Formats. The NQF then
convenes an expert panel to review the
comments received and provide
feedback. The NQF began this process
with feedback on AHRQ’s 0.1 Beta
release of the Common Formats in 2008.
Based upon the expert panel’s feedback,
AHRQ, in conjunction with the PSWG,
revises and refines the Common
Formats.
The Agency is specifically interested
in obtaining feedback from both the
private and public sectors on the new
Common Formats—Hospital Version 1.2
to guide the improvement of the
formats. Information on how to
comment and provide feedback on the
Common Formats—Hospital Version
1.2, is available at the NQF Web site for
Common Formats: https://
www.Quality.forum.ORG/projects/
commonformats.aspx.
The process for updating and refining
the formats will continue to be an
iterative one. Future versions of the
Common Formats will be developed for
ambulatory settings, such as ambulatory
surgery centers and physician and
practitioner offices. More information
on the Common Formats can be
obtained through AHRQ’s PSO Web site:
https://www.PSO.AHRQ.gov/.
Dated: April 5, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–8743 Filed 4–12–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
pmangrum on DSK3VPTVN1PROD with NOTICES
Agency for Healthcare Research and
Quality
Correction—Solicitation for
Nominations for Members of the U.S.
Preventive Services Task Force
(USPSTF)
The original date of publication for
this Federal Register notice was March
28, 2012, Volume 77, Number 60, pages
18823–18825. On this publication,
Gloria Washington’s email address is
incorrect in two places of page 18824
under subheadings ADDRESSES: and FOR
VerDate Mar<15>2010
14:16 Apr 12, 2012
Jkt 226001
FURTHER INFORMATION CONTACT:. The
correct email address for Gloria
Washington is: USPSTFmember
nominations@AHRQ.HHS.GOV
Dated: April 4, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012–8737 Filed 4–12–12; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Scientific Information Request on
Treatment of Tinnitus
Agency for Healthcare Research
and Quality (AHRQ), HHS.
ACTION: Request for scientific
information submissions.
AGENCY:
The Agency for Healthcare
Research and Quality (AHRQ) is seeking
scientific information submissions from
manufacturers of cochlear implants,
sound masking devices, hearing aids,
and transcranial magnetic stimulation
medical devices. Scientific information
is being solicited to inform our
Comparative Effectiveness Review of
Evaluation and Treatment of Tinnitus,
which is currently being conducted by
the Evidence-based Practice Centers for
the AHRQ Effective Health Care
Program. Access to published and
unpublished pertinent scientific
information on this device will improve
the quality of this comparative
effectiveness review. AHRQ is
requesting this scientific information
and conducting this comparative
effectiveness review pursuant to Section
1013 of the Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173.
DATES: Submission Deadline on or
before May 14, 2012.
ADDRESSES: Online submissions:
https://effectivehealthcare.AHRQ.gov/
index.cfm/submitscientific-informationpackets/. Please select the study for
which you are submitting information
from the list of current studies and
complete the form to upload your
documents.
Email submissions:
ehcsrc@ohsu.edu (please do not send
zipped files—they are automatically
deleted for security reasons).
Print submissions: Robin Paynter,
Oregon Health and Science University,
Oregon Evidence-based Practice Center,
3181 SW Sam Jackson Park Road, Mail
Code: BICC, Portland, OR 97239–3098.
SUMMARY:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
FOR FURTHER INFORMATION CONTACT:
Robin Paynter, Research Librarian,
Telephone: 503–494–0147 or Email:
ehcsrc@ohsu.edu.
SUPPLEMENTARY INFORMATION: In
accordance with Section 1013 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003, Public Law 108–173, the Agency
for Healthcare Research and Quality has
commissioned the Effective Health Care
(EHC) Program Evidence-based Practice
Centers to complete a comparative
effectiveness review of the evidence for
evaluation and treatment of tinnitus.
The EHC Program is dedicated to
identifying as many studies as possible
that are relevant to the questions for
each of its reviews. In order to do so, we
are supplementing the usual manual
and electronic database searches of the
literature by systematically requesting
information (e.g., details of studies
conducted) from medical device
industry stakeholders through public
information requests, including via the
Federal Register and direct postal and/
or online solicitations. We are looking
for studies that report on treatment of
tinnitus, including those that describe
adverse events, as specified in the key
questions detailed below. The entire
research protocol, including the key
questions, is also available online at:
https://www.effectivehealthcare.AHRQ.
gov/index.cfm/search-for-guidesreviews-and-reports/?pageaction=
displayproduct&productid=811#4755.
This notice is a request for industry
stakeholders to submit the following:
• A current product label, if
applicable (preferably an electronic PDF
file).
• Information identifying published
randomized controlled trials and
observational studies relevant to the
clinical outcomes. Please provide both a
list of citations and reprints if possible.
• Information identifying
unpublished randomized controlled
trials and observational studies relevant
to the clinical outcomes. If possible,
please provide a summary that includes
the following elements: study number,
study period, design, methodology,
indication and diagnosis, proper use
instructions, inclusion and exclusion
criteria, primary and secondary
outcomes, baseline characteristics,
number of patients screened/eligible/
enrolled/lost to withdrawn/follow-up/
analyzed, and effectiveness/efficacy and
safety results.
• Registered ClinicalTrials.gov
studies. Please provide a list including
the ClinicalTrials.gov identifier,
condition, and intervention.
Your contribution is very beneficial to
this program. AHRQ is not requesting
E:\FR\FM\13APN1.SGM
13APN1
Agencies
[Federal Register Volume 77, Number 72 (Friday, April 13, 2012)]
[Notices]
[Pages 22322-22324]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8743]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Common Formats for Patient Safety Data Collection and Event
Reporting
AGENCY: Agency for Healthcare Research and Quality (AHRQ), HHS.
ACTION: Notice of Availability--New Common Format.
-----------------------------------------------------------------------
SUMMARY: As authorized by the Secretary of HHS, AHRQ coordinates the
development of a set of common definitions and reporting formats
(Common Formats) for reporting patient safety events to Patient Safety
Organizations (PS0s). The purpose of this notice is to announce the
availability of new Common Formats--Hospital Version 1.2 for public
review and comment.
DATES: Ongoing public input.
ADDRESSES: The new Common Formats--Hospital Version 1.2, version dated
April 2012, and the remaining Common Formats can be accessed
electronically at the following HHS Web site: https://www.PSO.AHRQ.gov/.
FOR FURTHER INFORMATION CONTACT: Cathryn Niane, Center for Quality
Improvement and Patient Safety, AHRQ, 540 Gaither Road, Rockville, MD
20850; Telephone (toll free): (866) 403-3697;
[[Page 22323]]
Telephone (local): (301) 427-1111; TTY (toll free): (866) 438-7231; TTY
(local): (301) 427-1130; Email: PSO.AHRQ.hhs.gov.
SUPPLEMENTARY INFORMATION:
Background
The Patient Safety and Quality Improvement Act of 2005, 42 U.S.C.
299b-21 to b-26, (Patient Safety Act) provides for the formation of
PS0s, which collect, aggregate, and analyze confidential information
regarding the quality and safety of healthcare delivery. The Patient
Safety Act (at 42 U.S.C. 299b-23) authorizes healthcare providers to
voluntarily collect and submit in a standardized manner, as explained
in the related Patient Safety and Quality Improvement Final Rule, 42
CFR part 3 (Patient Safety Rule), published in the Federal Register on
November 21, 2008: 73 FR 70731-70814. The collection of patient safety
work product allows the aggregation of sufficient data to identify and
address underlying causal factors of patient safety problems.
The Patient Safety Act and Patient Safety Rule establish a
framework by which doctors, hospitals, skilled nursing facilities, and
other healthcare providers may assemble information regarding patient
safety events and quality of care. Information that is assembled and
developed by providers for reporting to PSOs and the information
received and analyzed by PSOs--called ``patient safety work product''--
is privileged and confidential. Patient safety work product is used to
identify events, patterns of care, and unsafe conditions that increase
risks and hazards to patients. Definitions and other details about PSOs
and patient safety work product are included in the Patient Safety Act
and Patient Safety Rule which can be accessed electronically at: https://www.PSO.AHRQ.gov/REGULATIONS/REGULATIONS.htm.
Definition of Common Formats
The term ``Common Formats'' refers to the common definitions and
reporting formats, specified by AHRQ, that allow health care providers
to collect and submit standardized information regarding patient safety
events. The Common Formats are not intended to replace any current
mandatory reporting system, collaborative/voluntary reporting system,
research-related reporting system, or other reporting/recording system;
rather the formats are intended to enhance the ability of health care
providers to report information that is standardized both clinically
and electronically.
In collaboration with the interagency Federal Patient Safety
Workgroup (PSWG), the National Quality Forum (NQF) and the public, AHRQ
has developed Common Formats for two settings of care--acute care
hospitals and skilled nursing facilities--in order to facilitate
standardized data collection. The scope of Common Formats applies to
all patient safety concerns including: Incidents--patient safety events
that reached the patient, whether or not there was harm; near misses or
close calls--patient safety events that did not reach the patient; and
unsafe conditions--circumstances that increase the probability of a
patient safety event.
AHRQ's Common Formats include:
Event descriptions (descriptions of patient safety events
and unsafe conditions to be reported);
Specifications for patient safety aggregate reports and
individual event summaries;
Delineation of data elements to be collected for different
types of events to populate the reports;
A user's guide and quick guide, and
Technical specifications for electronic data collection
and reporting.
The technical specifications promote standardization of collected
patient safety event information by specifying rules for data
collection and submission, as well 'as by providing guidance for how
and when to create data elements, their valid values, conditional and
go-to logic, and reports. These specifications will ensure that data
collected by PSOs and other entities have comparable clinical meaning.
They also provide direction to software developers, so that the Common
Formats can be implemented electronically, and to PS0s, so that the
Common Formats can be submitted electronically to the PSO Privacy
Protection Center (PPC) for data de-identification and transmission to
the Network of Patient Safety Databases (NPSD).
The Common Formats include two general types of formats, generic
and event-specific. The generic Common Formats pertain to all patient
safety concerns. The three generic formats are: Healthcare Event
Reporting Form, Patient Information Form, and Summary of Initial
Report. The event-specific Common Formats pertain to frequently-
occurring and/or serious patient safety events.
Since the initial release of the Common Formats in August 2008,
AHRQ regularly revises the formats based upon public comment. The
Common Formats--Hospital Version 1.2 features new content to
incorporate the event specific formats entitled Venous Thromboembolism
(VTE) and Device or Medical/Surgical Supply including Health
Information Technology (HIT) Device. Common Formats--Hospital Version
1.2, which also includes minor changes to existing modules and
technical specifications, is available at the PSO PPC Web site: https://www.PSOPPC.ORG/web/patientsafety.
Common Formats Development
In anticipation of the need for Common Formats, AHRQ began their
development by creating an inventory of functioning private and public
sector patient safety reporting systems. This inventory provides an
evidence base that informs construction of the Common Formats. The
inventory includes many systems from the private sector, including
prominent academic settings, hospital systems, and international
reporting systems (e.g., from the United Kingdom and the Commonwealth
of Australia). In addition, virtually all major Federal patient safety
reporting systems are included, such as those from the Centers for
Disease Control and Prevention (CDC), the Food and Drug Administration
(FDA), the Department of Defense (DoD), and the Department of Veterans
Affairs (VA).
Since February 2005, AHRQ has convened the PSWG to assist AHRQ with
developing and maintaining the Common Formats. The PSWG includes major
health agencies within HHS--CDC, Centers for Medicare & Medicaid
Services, FDA, Health Resources and Services Administration, Indian
Health Service, National Institutes of Health, National Library of
Medicine, Office of the National Coordinator for Health Information
Technology, Office of Public Health and Science, and Substance Abuse
and Mental Health Services Administration--as well as the DoD and VA.
When developing Common Formats, AHRQ first reviews existing patient
safety event reporting systems from a variety of health care
organizations. In collaboration with the PSWG and Federal subject
matter experts, AHRQ drafts and releases beta versions of the Common
Formats for public review and comment. The PSWG assists AHRQ with
assuring the consistency of definitions/formats with those of relevant
government agencies as refinement of the Common Formats continues. To
the extent practicable, the Common Formats are also aligned with World
Health Organization (WHO) concepts, framework, and definitions
[[Page 22324]]
contained in their draft International Classification for Patient
Safety (ICPS).
Commenting on Common Formats Hospital 1.2
To allow for greater participation by the private sector in the
subsequent development of the Common Formats, AHRQ engaged the NQF, a
non-profit organization focused on health care quality, to solicit
comments and advice to guide the further refinement of the Common
Formats. The NQF then convenes an expert panel to review the comments
received and provide feedback. The NQF began this process with feedback
on AHRQ's 0.1 Beta release of the Common Formats in 2008. Based upon
the expert panel's feedback, AHRQ, in conjunction with the PSWG,
revises and refines the Common Formats.
The Agency is specifically interested in obtaining feedback from
both the private and public sectors on the new Common Formats--Hospital
Version 1.2 to guide the improvement of the formats. Information on how
to comment and provide feedback on the Common Formats--Hospital Version
1.2, is available at the NQF Web site for Common Formats: https://www.Quality.forum.ORG/projects/commonformats.aspx.
The process for updating and refining the formats will continue to
be an iterative one. Future versions of the Common Formats will be
developed for ambulatory settings, such as ambulatory surgery centers
and physician and practitioner offices. More information on the Common
Formats can be obtained through AHRQ's PSO Web site: https://www.PSO.AHRQ.gov/.
Dated: April 5, 2012.
Carolyn M. Clancy,
Director.
[FR Doc. 2012-8743 Filed 4-12-12; 8:45 am]
BILLING CODE 4160-90-M